Zomedica pharmaceuticals corp. (ZOM)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16
Cash flows used in operating activities:
Net loss

-19,784

-16,647

-8,065

-5,740

Adjustments for
Depreciation

277

203

89

43

Amortization - intangible assets

1

2

2

2

Amortization - right-of-use asset

509

0

-

-

Loss on fixed asets

-1

-69

-

-

Stock issued for services

792

5,651

275

15

Stock-based compensation

2,539

7

849

1,467

Change in non-cash operating working capital
Trade and other receivable

13

25

9

21

Prepaid expenses

-239

124

205

-7

Deposits

-92

1,832

124

890

Accounts payable and accrued liabilities

-288

1,547

94

552

-15,634

-11,147

-7,093

-4,562

Cash flows from financing activities:
Cash proceeds from issuance of preferred shares

12,000

-

-

-

Cash proceeds from issuance of common shares

3,000

8,282

6,570

4,755

Cash received from stock option exercises

600

2,034

979

35

Cash paid on stock issuance costs

708

58

56

115

Cash received on amalgamation

-

-

-

108

Repayments of shareholder loan

-

-

-6

2

14,891

10,258

7,486

4,786

Cash flows used in investing activities:
Cash received from sale of fixed assets

-

9

-

-

Investment in intangibles

531

-

-

9

Investment in property and equipment

155

627

171

231

-686

-618

-171

-241

Decrease in cash and cash equivalents

-1,429

-1,507

221

-17

Supplemental cash flow information:
Interest Paid

18

-

-

-